EX-99.1 2 ss1282939_ex9901.htm JOINT FILING AGREEMENT

Exhibit 1

 

JOINT FILING AGREEMENT

                 

 The undersigned hereby agree that the Statement on Schedule 13D, dated August 24, 2022, with respect to the ordinary shares of Arcutis Biotherapeutics, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 26th day of August 2022.

 

  ORBIMED ADVISORS LLC  
       
       
  By: /s/ Carl L. Gordon  
    Name: Carl L. Gordon  
    Title: Member  
       
  ORBIMED CAPITAL GP VII LLC  
       
  By: ORBIMED ADVISORS LLC, its Managing Member
       
  By: /s/ Carl L. Gordon  
    Carl L. Gordon  
   

Title: Member of OrbiMed Advisors LLC

 

  
  ORBIMED CAPITAL LLC  
       
  By: /s/ Carl L. Gordon  
    Carl L. Gordon  
    Title: Member